Clinical Trial Update: This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov update reports two-year follow-up results from a Phase 3 study assessing long-term safety, tolerability, and efficacy of two doses of ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED